Omicron variant of COVID-19 infection
Conditions
Interventions
The control group:Ten Qingyang Yin granules: 2 times a day, 1 bag once, for 1-7 days.
Sponsors
Shuguang Hospital affiliated with Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Coronavirus infection (nucleic acid tests or antigen test was positive, CT value <40), mild or asymptomatic coronavirus carriers; 2. Entered the fangcang hospital which was taken over by Shuguang Hospital affiliated with Shanghai University of Traditional Chinese Medicine; 3. who have given informed consent and accept the treatment of Shiwei Qingyang Decoction; 4. aged from 18 to 75 years Note: only those who meet the above 4 criteria can be included in this study.
Exclusion criteria
Exclusion criteria: 1. unwilling to accept the treatment of Shiwei Qingyang Decoction; 2, unconsciousness, failure to express subjective discomfort symptoms and mental disorder patients; 3, accompanied by more than one severe secondary progressive malignancy or other severe wasting diseases; 4. Patients with severe symptoms of depression and anxiety; 5. Age 75 Note: patients who met any of the above criteria were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nucleic acid detection of COVID-19; | — |
Countries
China
Contacts
Public ContactJiatuo Xu
Outcome results
None listed